Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Cymbalta
Generic name / active ingredient
duloxetine
Dosage-form class
Duloxetine hydrochloride delayed-release oral capsules: 20 mg, 30 mg and 60 mg (as listed in the U.S. public label; this page separately displays 60-, 30- and 30-capsule bottle panels)
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check CYMBALTA, duloxetine, delayed-release capsule, labelled strength per capsule and target market together. A shared generic name, similar use or nearby mg number does not prove interchangeability with another ordinary capsule, tablet or psychiatric medicine.
  • Enteric/delayed-release design cannot be handled by experience through opening, chewing, crushing, halving or mixing with food. Any handling question must return to the current label and pharmacist guidance for the exact product; a webpage is not instructions for altering a formulation.
  • The label identifies situations needing review involving the liver, blood pressure, bleeding tendency, alcohol and other serotonin-affecting medicines. With multiple medicines, tell a professional about every prescription, OTC product, herb and alcohol use together.
  • Do not suddenly self-stop, increase or change to another medicine because pain, mood or sleep changes. Tapering, stopping and conversion need a prescribing-team plan; severe psychiatric symptoms or an acute concern need local medical-support pathways.

Reviewed presentation examples — compare every field

  • Duloxetine 20 mg per capsule; 60-capsule bottleNDC 0002-3235-60
  • Duloxetine 30 mg per capsule; 30-capsule bottleNDC 0002-3240-30
  • Duloxetine 60 mg per capsule; 30-capsule bottleNDC 0002-3270-30

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image